Class of Stock [Axis] Series C Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] US Government Agencies Debt Securities [Member] Preferred Stock Blank Check [Member] PreFunded Warrants [Member] Warrant [Member] Series G Warrants [Member] Award Type [Axis] Restricted Stock [Member] Title and Position [Axis] Employees and Directors [Member] Restricted Stock Units (RSUs) [Member] Chief Executive Officer [Member] Share-Based Payment Arrangement, Option [Member] Series J Warrants [Member] Series K Warrants [Member] Geographical [Axis] UNITED STATES ITALY POLAND GERMANY Other Countries [Member] Customer [Axis] Customer A [Member] Concentration Risk Benchmark [Axis] Sale [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer B [Member] Product and Service [Axis] Research and Development [Member] Location, Statement of Income, Balance [Axis] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS: Cash and cash equivalents Marketable securities Accounts receivable: Trade, net Other Prepaid expenses Inventory TOTAL CURRENT ASSETS NON-CURRENT ASSETS: Long term deposit Property, plant and equipment, net Operating lease right of use assets Fund in respect of employee rights upon retirement TOTAL NON-CURRENT ASSETS TOTAL ASSETS CURRENT LIABILITIES: Accounts payable and accruals: Trade Other TOTAL CURRENT LIABILITIES LONG-TERM LIABILITIES- Operating lease liabilities net of current maturities Liability for employee rights upon retirement and others TOTAL LONG-TERM LIABILITIES TOTAL LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES EQUITY: Common stock, par value $0.0001 per share; 150,000,000 shares authorized at March 31, 2026 and December 31, 2025; 46,838,963 and 43,532,281 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Preferred C shares, par value $0.0001 per share; 1,172,000 shares authorized at March 31, 2026 and December 31, 2025; 1,718 shares issued and outstanding at March 31, 2026 and December 31 2025 Additional paid-in capital Accumulated deficit Total equity Total liabilities and equity Statement [Table] Statement [Line Items] Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] REVENUES COST OF REVENUES GROSS PROFIT OPERATING EXPENSES: Research and development Selling and marketing General and administrative Total operating expenses LOSS FROM OPERATIONS FINANCIAL INCOME, net NET LOSS NET LOSS PER SHARE - basic NET LOSS PER SHARE - diluted WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - diluted Balance Balance, shares Net loss Exercise of pre-funded warrants Exercise of pre-funded warrants, shares Issuance of common stock, included at the market offering net of $22 issuance costs Issuance of common shares, Included at the market offering net of issuance costs, shares Share-based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures of shares Share-based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures of shares, shares Balance Balance, shares Statement of Stockholders' Equity [Abstract] Market offering costs Shares restricted stock award, forfeited Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments required to reconcile net loss to net cash used in operating activities: Depreciation Change in fair value of marketable securities, net of interest received Change in liability for employees rights upon retirement Other financial expenses (income) Change in operating right of use asset and operating leasing liability Share-based compensation expenses Loss (gains) on amounts funded in respect of employee rights upon retirement, net Changes in operating assets and liability items: Decrease in prepaid expenses Increase in trade receivables Decrease (increase) in other receivables (Increase) decrease in inventory Increase in trade payables Decrease in other payables Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property, plant and equipment Investments in marketable securities Proceeds from matured marketable securities Amounts funded in respect of employee rights upon retirement Net cash provided by investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of shares Net cash provided by financing activities EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD SUPPLEMENT NON-CASH INVESTING AND FINANCING ACTIVITIES: Receivable on account of share issuance Non-cash purchase of property and equipment Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS BASIS OF PRESENTATION Accounting Changes and Error Corrections [Abstract] RECENTLY ADOPTED AND ISSUED ACCOUNTING PRONOUNCEMENTS Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Investments, Debt and Equity Securities [Abstract] EQUITY Related Party Transactions [Abstract] RELATED PARTIES TRANSACTIONS Earnings Per Share [Abstract] NET LOSS PER SHARE Investments, All Other Investments [Abstract] FINANCIAL INSTRUMENTS Inventory Disclosure [Abstract] INVENTORY Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUALS - OTHER Revenue from Contract with Customer [Abstract] DISAGGREGATED REVENUE AND ENTITY WIDE DISCLOSURES Segment Reporting [Abstract] SEGMENT INFORMATION SCHEDULE OF FINANCIAL ASSETS SUBJECT TO FAIR VALUE MEASUREMENTS SCHEDULE OF CHANGES IN FAIR VALUE OF MARKETABLE SECURITIES SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES SCHEDULE OF INVENTORIES SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUALS - OTHER SCHEDULE OF REVENUES ATTRIBUTED TO GEOGRAPHIC AREAS SCHEDULE OF REVENUES ATTRIBUTED TO GEOGRAPHIC AREAS BY PRINCIPAL CUSTOMERS SCHEDULE OF SEGMENT REVENUE Subsequent Event [Table] Subsequent Event [Line Items] Customer returns Inventory impairment Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Money market funds U.S government bonds Cost of marketable securities Balance at beginning of the period Additions Maturity Interest Received Changes in fair value during the period Balance at end of the period EquityTable [Table] EquityLineItems [Line Items] Capital stock shares authorized Capital stock par value Common stock shares authorized Preferred stock shares authorized Preferred stock outstanding Preferred stock convertible shares issuable Preferred stock convertible value issuable Number of underlying common stock Number of warrants expired Number of restricted stock units, granted Fair value stock option price IssuanceOfWarrantsTable [Table] IssuanceOfWarrantsLineItems [Line Items] Weighted average exercise price Expiration date Related Party Transaction [Table] Related Party Transaction [Line Items] Related party transaction, amount Weighted average number of common stock Weighted average Vested restricted stock units Weighted average Pre-funded Warrants Total Weighted average number of ordinary shares used in computing net loss per share - basic Total Weighted average number of ordinary shares used in computing net loss per share - diluted Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Diluted loss per share Unvested restricted stock Finished goods Work in process Raw materials and supplies Total inventory Employees and employee institutions Accrued vacation and recreation pay Accrued expenses Clinical trial accrual Current Operating lease liabilities Other Accounts Payable and Accruals - Other Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenues Sales percentage Segment Reporting [Table] Segment Reporting [Line Items] Cost of Revenues: Material and Labor Other cost of revenues Total Cost of Revenues Research and development (R&D) Payroll and Benefits Share based compensation Clinical trials Other R&D Total Research and development Selling and marketing (S&M) Other S&M Total Selling and marketing General and administrative (G&A) Other G&A Total General and administrative Financial Income, net; Operating segments Reportable segments Value stock warrants exercised. Shares stock warrants exercised. Share based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures. Changes in fair value of marketable securities. Change in liability for employees rights upon retirement. Change in operating lease assets and liabilities. Loss gain on amounts funded in respect of employee rights upon retirement net Marketable securities. Amounts with drawn in respect of employee rights upon retiremen Non cash purchase of property and equipment. Receivable on account of share issuance. Fair Value Of Marketable Securities Classified By Maturity [Table Text Block] Changes in fair value marketable securities. Capital stock par value. Preferred Stock Blank Check [Member] PreFunded Warrants [Member] Series J Warrants [Member] Series K Warrants [Member] Warrants expired. Series G Warrants [Member] Employees and Directors [Member] Weighted average number of shares ordinary shares issued basic. Weighted average number of shares restricted stock units. Weighted average number of shares prefunded warrants. Clinical trial accrual. Accrued operating lease liabilities current. Revenue From External Customers By Geographic Area [Table Text Block] Sale [Member] Clinical trials. Research and Development [Member] Class of warrant or righst date from which warrants or right exercisable. Share based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures shares. Customer B [Member] Other Countries [Member] Customer A [Member] Assets, Current Assets, Noncurrent Assets Accounts Payable, Other, Current Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Shares, Outstanding ChangesInFairValueOfMarketableSecurities ChangeInLiabilityForEmployeesRightsUponRetirement Other Noncash Income (Expense) ChangeInRightOfUseAssetAndLeasingLiability LossGainOnAmountsFundedInRespectOfEmployeeRightsUponRetirementNet Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Increase (Decrease) in Inventories Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment AmountsWithdrawnInRespectOfEmployeeRightsUponRetirementNet Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Payments to Acquire Held-to-Maturity Securities Proceeds from Interest Received Other Accrued Liabilities, Current